TR200101648T2 - İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller - Google Patents

İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller

Info

Publication number
TR200101648T2
TR200101648T2 TR2001/01648T TR200101648T TR200101648T2 TR 200101648 T2 TR200101648 T2 TR 200101648T2 TR 2001/01648 T TR2001/01648 T TR 2001/01648T TR 200101648 T TR200101648 T TR 200101648T TR 200101648 T2 TR200101648 T2 TR 200101648T2
Authority
TR
Turkey
Prior art keywords
purification
sulfonated
reducing agents
solid phase
relates
Prior art date
Application number
TR2001/01648T
Other languages
English (en)
Inventor
Maertens Geert
Louwagie Joost
Bosman Alfons
Sablon Erwin
Zrein Maan
Original Assignee
Innogenetics N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8237028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200101648(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics N.V. filed Critical Innogenetics N.V.
Publication of TR200101648T2 publication Critical patent/TR200101648T2/tr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Mevcut bulus; kati faz bagisiklik tahlili (immünoassay) ile ilgili olup, bahsedilen kati faz üzerinde, indirgeyici bir ajanin varliginda, bir antijenden olusmaktadir. Bunun yaninda, mevcut bulus; sistein içeren, rekombinant olarak tanimlanan bir proteini saflastirmak için bir metot ile ilgili olup, asagidaki basamaklardan en az 2, tersihen 3 veya 4'ü ve hatta daha çok da, tercihen tümünden olusmaktadir: (a) bir lisatin rekombinant tasiyici canli hücrelerinden sülfonasyonu veya guanidinyum klorürün varliginda, rekombinant tasiyici canli hücrelerinin belirtilerinin giderek kaybolmasi (lisis), arkasindan da hücre lisatinin sülfonasyonu, (b) tercihen, hücre kalintilarinin uzaklastirilmasindan sonra, bir zvitteryonik deterjan ile muamele, (c) rekombinant proteinin sülfonasyonlu versiyonunun saflastirilmasi veya ardisik olarak gerçeklestirilen zvitteryonik deterjanin uzaklastirilmasi ile, sülfonasyonlu rekombinant proteinin saflastirilmasi olup, bahsedilen saflastirma islemi, DEVAMI VAR.
TR2001/01648T 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller TR200101648T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98870087 1998-04-17

Publications (1)

Publication Number Publication Date
TR200101648T2 true TR200101648T2 (tr) 2002-06-21

Family

ID=8237028

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2000/03024T TR200003024T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.
TR2001/01648T TR200101648T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
TR2002/02213T TR200202213T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
TR2001/01647T TR200101647T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2000/03024T TR200003024T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2002/02213T TR200202213T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
TR2001/01647T TR200101647T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.

Country Status (22)

Country Link
US (1) US7935490B2 (tr)
EP (2) EP1071955B2 (tr)
JP (2) JP2002512370A (tr)
KR (1) KR20010042807A (tr)
CN (1) CN1305589A (tr)
AT (2) ATE278960T1 (tr)
AU (1) AU751362B2 (tr)
BR (1) BRPI9909678B8 (tr)
CA (2) CA2324970C (tr)
CY (1) CY1108424T1 (tr)
CZ (1) CZ298268B6 (tr)
DE (2) DE69920895T3 (tr)
DK (2) DK1471074T3 (tr)
ES (2) ES2230851T5 (tr)
HK (1) HK1036653A1 (tr)
HU (1) HUP0101719A3 (tr)
IL (1) IL138791A0 (tr)
PL (1) PL343469A1 (tr)
PT (2) PT1071955E (tr)
TR (4) TR200003024T2 (tr)
WO (1) WO1999054735A1 (tr)
ZA (1) ZA200005445B (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999067285A1 (en) * 1998-06-24 1999-12-29 Innogenetics N.V. Particles of hcv envelope proteins: use for vaccination
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6960569B2 (en) * 2000-08-17 2005-11-01 Tripep Ab Hepatitis C virus non-structural NS3/4A fusion gene
US7314925B2 (en) * 2001-04-24 2008-01-01 Innogenetics N.V. Constructs and methods for expression of recombinant HCV envelope proteins
JP2004108914A (ja) * 2002-09-18 2004-04-08 Kudo Norio コラーゲンの測定方法
CA2504711A1 (en) * 2002-11-08 2004-05-21 Innogenetics N.V. Hcv vaccine compositions comprising e1 and ns3 peptides
US20050014136A1 (en) * 2003-05-28 2005-01-20 Innogenetics N.V. Modified HCV NS5
DE602004029707D1 (de) * 2003-10-28 2010-12-02 Advanced Life Science Inst Inc Verfahren zum nachweis von hepatitis-c-virus
EP2041572A1 (en) * 2006-07-07 2009-04-01 Pall Corporation Use of denaturing agents during affinity capture
AU2008276488A1 (en) * 2007-07-16 2009-01-22 Pfizer Inc. Methods of improving a genomic marker index of dairy animals and products
AU2008300011A1 (en) * 2007-09-12 2009-03-19 Pfizer, Inc. Methods of using genetic markers and related epistatic interactions
CN101883869A (zh) * 2007-10-03 2010-11-10 美国辉瑞有限公司 有角牛和无角牛的遗传标志及其相关方法
JP2011505872A (ja) * 2007-12-17 2011-03-03 ファイザー・インク 乳用動物および乳用生産物の遺伝的プロフィールを改良する方法
CN102089662B (zh) * 2008-07-16 2015-05-27 雷迪奥米特医学公司 高容量固相
CN102081018A (zh) * 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
JP6821562B2 (ja) * 2014-10-29 2021-01-27 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ Ｎｓ３捕捉ペプチドを使用して対象の抗ｈｃｖ抗体を検出するアッセイ
CN109870581B (zh) * 2017-12-04 2021-05-04 厦门万泰凯瑞生物技术有限公司 一种定量检测HBsAg的试剂盒及方法
CN109678954B (zh) * 2018-12-29 2022-01-07 山东莱博生物科技有限公司 一对能够特异性识别hcv ns3蛋白的单克隆抗体及其应用
CN110988362B (zh) * 2019-12-20 2023-11-14 迈克生物股份有限公司 抗组蛋白抗体测定试剂、试剂盒及其使用方法
CN112225783B (zh) * 2020-09-16 2021-08-31 东莞市朋志生物科技有限公司 Hcv重组抗原及其突变体
CN112285361B (zh) * 2020-09-27 2023-12-05 中国人民解放军空军军医大学 排除抗-cd38单克隆抗体药物对抗人球蛋白检测干扰的试剂
CN113219169B (zh) * 2021-05-22 2021-12-17 北京金诺百泰生物技术有限公司 生物检测用封闭剂及其制备方法、包被板及应用该包被板的试剂盒

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139526A2 (en) * 1983-10-20 1985-05-02 Warner-Lambert Company An insolubilized stable specific binding protein
US4616078A (en) * 1985-04-08 1986-10-07 Eli Lilly And Company Process for purifying proinsulin-like materials
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
ATE92633T1 (de) 1988-05-11 1993-08-15 Abbott Lab Verfahren zur erhoehung der spezifizitaet in kompetitiven immuntests.
US4923967A (en) * 1988-09-26 1990-05-08 Eli Lilly And Company Purification and refolding of recombinant proteins
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
EP0527788B1 (en) 1990-04-04 2004-06-30 Chiron Corporation Hepatitis c virus protease
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
UA40572C2 (uk) * 1991-06-24 2001-08-15 Чірон Корпорейшн Поліпептид, що містить укорочену послідовність вірусу гепатиту с, ізольований епітоп, реагент для імуноаналізу на вірус гепатиту с (варіанти), спосіб виявлення наявності антитіл (варіанти)
JP3225468B2 (ja) 1992-08-28 2001-11-05 ダイナボット株式会社 抗体測定用試薬
DE69435023T2 (de) 1993-04-27 2008-09-11 N.V. Innogenetics S.A. Sequenzen der genotype des hepatitis-c-virus sowie ihre verwendung als arzneimittel und diagnostika
EP0725824B1 (en) 1993-11-04 2003-04-09 Innogenetics N.V. Immunodominant human t-cell epitopes of hepatitis c virus
ES2167372T3 (es) 1994-06-23 2002-05-16 Energy Answers Corp Sistema para la obtencion de productos derivados de la ceniza y de energia a partir de residuos rechazados.
US6150134A (en) * 1994-07-29 2000-11-21 Innogenetics, N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
DE4428705A1 (de) 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
JPH0862219A (ja) 1994-08-19 1996-03-08 Dainabotsuto Kk 還元型抗原に対する抗体アッセイ試薬及びそれを使用した測定方法
EP1076092A3 (en) 1994-10-21 2001-03-28 Innogenetics N.V. Sequences of hepatitis C virus type10 and their use as prophylactic, therapeutic and diagnostic agents
US5705330A (en) 1995-04-14 1998-01-06 Abbott Laboratories Chemiluminescent immunoassay for antibody detection
US5616460A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
DE69734776T2 (de) 1996-05-24 2006-08-17 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Fusionsprotein mit multiplen Epitopen
JP4163756B2 (ja) * 1997-01-13 2008-10-08 ローム アンド ハース エレクトロニック マテリアルズ シーエムピー ホウルディングス インコーポレイテッド ホトリソグラフィーによって形成された表面パターンを有するポリマー研磨パッド及びこれに関する方法

Also Published As

Publication number Publication date
DE69920895D1 (de) 2004-11-11
DE69939132D1 (de) 2008-08-28
ES2230851T3 (es) 2005-05-01
JP2002512370A (ja) 2002-04-23
CA2658218C (en) 2014-10-28
PL343469A1 (en) 2001-08-13
AU751362B2 (en) 2002-08-15
CA2324970C (en) 2009-06-30
TR200101647T2 (tr) 2002-06-21
ATE278960T1 (de) 2004-10-15
JP3974620B2 (ja) 2007-09-12
EP1471074B1 (en) 2008-07-16
EP1071955A1 (en) 2001-01-31
TR200003024T2 (tr) 2000-12-21
CA2658218A1 (en) 1999-10-28
BR9909678B1 (pt) 2013-11-12
TR200202213T2 (tr) 2002-11-21
IL138791A0 (en) 2001-10-31
EP1471074A3 (en) 2004-11-10
JP2005185285A (ja) 2005-07-14
CN1305589A (zh) 2001-07-25
BR9909678A (pt) 2000-12-19
HUP0101719A2 (hu) 2001-09-28
PT1471074E (pt) 2008-10-23
DK1071955T3 (da) 2005-02-07
CZ20003819A3 (cs) 2001-10-17
HUP0101719A3 (en) 2006-05-29
EP1471074A2 (en) 2004-10-27
KR20010042807A (ko) 2001-05-25
US7935490B2 (en) 2011-05-03
CY1108424T1 (el) 2014-04-09
EP1071955B2 (en) 2009-02-18
DK1471074T3 (da) 2008-11-17
DK1071955T4 (da) 2009-06-15
WO1999054735A1 (en) 1999-10-28
CZ298268B6 (cs) 2007-08-08
ATE401340T1 (de) 2008-08-15
HK1036653A1 (en) 2002-01-11
ES2230851T5 (es) 2009-06-25
PT1071955E (pt) 2005-02-28
DE69920895T2 (de) 2005-10-13
DE69920895T3 (de) 2009-09-03
US20060263854A1 (en) 2006-11-23
CA2324970A1 (en) 1999-10-28
BRPI9909678B8 (pt) 2021-05-25
AU3817199A (en) 1999-11-08
EP1071955B1 (en) 2004-10-06
ZA200005445B (en) 2003-01-06
ES2310701T3 (es) 2009-01-16

Similar Documents

Publication Publication Date Title
TR200101648T2 (tr) İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
BR9908083A (pt) polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção de m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpo monoclonal, e, proteìna de fusão
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
DK1144447T3 (da) Dianostisk tuberkulosetest
Jerry et al. Stabilization of dissociable IgA2 proteins by secretory component
SHIPOLINI et al. The disulphide bridges of phospholipase A2 from bee venom
KR950008537A (ko) 엡스타인 바 비루스(ebv)에 대한 항체의 검출용 진단제
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
Oguiura et al. Quantification of crotamine, a small basic myotoxin, in South American rattlesnake (Crotalus durissus terrificus) venom by enzyme-linked immunosorbent assay with parallel-lines analysis
NO950977L (no) Nye forgrenede hydrid- og klasepeptider som er effektive ved diagnostisering og påvisning av ikke-A, ikke-B hepatit
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
BR0011624A (pt) Composições e processos para detectar treponema pallidum
BR0308095A (pt) Teste para anticorpos anti-ingap
RU98106859A (ru) Новое антитело, соединение с активностью ренина, содержащее новое антитело, и реактив для определения проренина с использованием нового антитела
BR9801000A (pt) Anticorpo, substância renina-ativa contendo o mesmo e reagente para ensaio de pro-renina usando o mesmo.
KR960034420A (ko) 적어도 2개의 c형간염바이러스관련펩티드로 이루어진 다량체항원펩티드
AU2002365248A1 (en) Detection of bovine viral diarrhea virus in hair samples
RU98106385A (ru) Пептиды tlp комплекса мочеполовой карциномы и их антитела
GB2289125A (en) Methods of assaying data-repairing enzymes and their alkylated derivatives
RU2000129528A (ru) Усовершенствованные иммунодиагностические анализы с использованием восстановителей
RU98114286A (ru) Иммуноферментная тест-система для выявления антител к возбудителю сифилиса
Smith et al. Enzymatic Cleavage of Polypeptides
YAMAKI et al. Presence of lower temperature-dependent antibody with low avidity to C100-3 (HCV) antigen in voluntary blood donors
KR950005322A (ko) 소의 소형 피로플라즈마 병원충 감염의 예방용 펩티드
UA58895A (uk) Тест-система імуноферментна (dia-chlamydia) для виявлення антитіл класів а та g до chlamydia trachomatis у сироватках та плазмі крові людини